Diag-Nose.Io Opens Houston Office Following Oversubscribed $2M Seed Round To Measure Respiratory Treatment Success Using Proteomics & AI
Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed roundHOUSTON, Jan.
Diag-Nose.Io, Graduate Of CDL-Seattle, Closes Oversubscribed $2M Seed Round To Transform Respiratory Care With AI-Driven Precision Medicine
Diag-Nose.io, a CDL-Seattle graduate, harnesses AI with RhinoMAPTM to redefine respiratory care, securing $2M in oversubscribed fundingSEATTLE, ...